Latest news with #UltraClear®
Cision Canada
29-05-2025
- Business
- Cision Canada
Acclaro Medical Raises $23 Million in Series B Funding Led by Accelmed Partners to Advance Groundbreaking 2910 nm Fiber Laser Technology
Accelmed $20 Million Investment with 3E Bioventures Capital Funding of $3 Million to Drive Innovation, Clinical Expansion, and Global Market Growth SMITHFIELD, R.I., May 29, 2025 /CNW/ -- Acclaro Medical, a pioneering medical technology company focused on developing cutting-edge solutions that improve patient care and redefine medical practices, proudly announces the successful completion of its Series B funding round. Led by Accelmed Partners with participation by existing investor 3E Bioventures Capital, the combined funding of $23 million marks a pivotal milestone in the company's journey to fulfill unmet aesthetic needs through its innovative 2910 nm fiber laser solution and other disruptive technologies. This capital infusion will help Acclaro accelerate the growth of its flagship products, UltraClear ® and AuraLux ™ and expedite global market expansion while advancing development of new trailblazing products in its pipeline. Acclaro Medical's UltraClear fiber laser is recognized by leading aesthetic professionals as a breakthrough in Total Skin Health that treats multiple skin layers to help reverse the signs of aging and gravity. The first of its kind 2910 nm cold ablative fiber laser, powered by proprietary 3DIntelliPulse ™ technology, delivers: "The funding is a testament to our unstoppable team and tremendous progress Acclaro has made in a very short duration." Post this Unparalleled clinical efficacy Superior patient experiences Unmatched versatility Significantly improved safety for all skin types, including previously high-risk skin-of-color patients. Its precision-engineered capabilities make it the ideal choice for practitioners seeking transformative results with minimal downtime, reduced patient discomfort and speedy healing. Complementing UltraClear, the AuraLux laser leverages the same exclusive Cool Pulse ™ technology and broadens accessibility for aesthetic providers and their patients while maintaining Acclaro's hallmark quality. "Securing this Series B investment is a powerful testament to our unstoppable team and the tremendous progress that Acclaro has made in a very short period of time," said Acclaro Medical CEO and Co-founder Helen Fang. "This funding empowers us to continue our strong growth and realize our vision of improving the quality of life for people of all skin colors and all ages worldwide." Shlomo Assa, President and co-founder of Acclaro Medical, noted: "We are thrilled to have the support of Accelmed as we expand our global and domestic footprint. This Series B funding is a strong vote of confidence in our mission to bring UltraClear and AuraLux to more people pursuing anti-aging solutions for healthier and younger-looking skin. It greatly enables us to accelerate product development, expand our team, and reach more customers globally – And we're just getting started!" The Series B funding will allow Acclaro Medical to leverage decades of Accelmed's operational and financial expertise, alongside 3E Bioventures' disciplined efficiency. Acclaro Medical is poised to execute its strategic plans and realize its vision of revolutionizing the aesthetic industry. These efforts will further cement the company's position as a leader in providing innovative, patient-centered skin health solutions. "Acclaro's unique cold laser fiber technology constitutes a game changer in laser aesthetics with the possibility for aesthetic practices to safely treat all skin types for all major indications using only one device," stated Daniel Cohen, Accelmed's venture partner with extensive experience leading successful Medtech & Biotech investments over the last 20 years. "Accelmed Partners is thrilled to lead this round of financing and accompany Acclaro' s management in this fantastic journey." About Acclaro Medical Founded in 2018 by world-class industry experts, Acclaro Medical is committed to developing, innovating and bringing to market game-changing solutions to address today's unmet medical, aesthetic and surgical practice needs. With a relentless commitment to innovation and a team of dedicated professionals, Acclaro Medical continues to push the boundaries and drive positive change in the aesthetic medical industry. Its proprietary 3DMIRACL ™ and Laser Coring ™ skin rejuvenation treatments are valued for offering unrivaled aesthetic results complemented by high patient comfort, rapid healing and utmost safety across all skin types. For more information, please visit About Accelmed Partners Accelmed, a leader in healthcare technology investing, is renowned for its private equity approach to a sector traditionally dominated by venture and early-stage growth firms. Its team of experienced industry veterans and company builders work closely as a trusted partner with portfolio management to improve operations, upgrade product portfolios, and strengthen commercial organizations. Accelmed's support and resources are designed to help portfolio companies like Acclaro Medical elevate its technology and achieve enduring success. The investment firm currently manages over $630 million of equity capital. For more information, please visit
Yahoo
10-04-2025
- Business
- Yahoo
Acclaro Medical Introduces AuraLux™ Fiber Laser: the Total Solution for Skin Health and Timeless Youth for All Aesthetic Providers and Patients
~ Next-Generation AuraLux Innovates Cold Fiber Laser Technology for Physician and MedSpa Practices Seeking Pioneering Preventative and Rejuvenation Treatments with Superior Safety, Less Discomfort and Minimal Downtime While Offering Practice Growth Opportunities SMITHFIELD, R.I., April 10, 2025 /PRNewswire/ -- Acclaro Medical today announced the launch of AuraLux™ cold fiber laser, an evolution of its successful 2910 nm laser technology, specifically developed as an exclusive treatment solution for total skin health and timeless youth across all aesthetic practices and patient demographics. AuraLux will be unveiled at The Medical Spa Show to be held at the Wynn Las Vegas on April 10-13, 2025, and hosted by the American MedSpa Association, a leading multi-faceted national organization for the medical spa industry. Capitalizing on Acclaro's winning UltraClear® cold ablative fiber laser, AuraLux is designed to prevent and correct the signs of skin aging using advanced engineering that produces a comfortable procedure to improve skin appearance with outstanding efficacy. AuraLux's CoolPulse™ technology automatically blends cold ablation and adjustable coagulation to precisely deliver the energy in the same channel for optimal results that minimize pain and downtime on all skin types. This approach triggers skin to restructure, produce new skin cells and initiate collagen remodeling for improvement of numerous skin conditions, including pre-aging flaws, fine lines, unwanted pigmentation, poor texture and scarring. With presets to ensure safety, AuraLux addresses every dimension of skin health, creating a curated treatment solution as a standalone procedure or integrated with other aesthetic treatments. "AuraLux embodies the benefits of our flagship 2910 nm fiber laser platform, including the advantages of our CoolPulse technology and clinical versatility, to give providers and their patients safe and effective preventative and age-revitalizing treatments for comprehensive skin health," said Shlomo Assa, Co-Founder and President of Acclaro Medical. "We know that laser treatments can be intimidating. The introduction of AuraLux Fiber Laser helps ensure widespread accessibility to transformative laser experiences with glowing outcomes that enhance appearance and empower patient confidence." AuraLux overcomes barriers to laser treatments such as pain, downtime and safety concerns, with four customizable modalities. These treatments accurately affect all skin layers, making it easier and more approachable for first timers as well as seasoned veterans: 3DMIRACL® targets the stratum corneum in a 10 to 15-minute prejuvenation treatment with improved surface texture and tone without the need for numbing cream in most cases REFRESH targets the stratum corneum to the epidermis to correct fine lines, moderate to mild sun damage, age spots and discoloration for healthy, radiant skin RENEW targets the dermis to produce deep collagen remodeling1 that improves scarring, addresses wrinkles and enhances overall skin health GLIDE is a novel in-motion technique that delivers randomized pulses to the treatment area, reducing the risk of hyperpigmentation and offering quicker treatments for large areas "The AuraLux Fiber Laser ushers in timeless youth and skin health while elevating our treatment outcomes and business economics," said Scott Gerrish, MD, a leading expert in regenerative medesthetics with practices in Vienna, VA and Scottdale, AZ. "Unlike other energy devices, AuraLux is engineered to minimize pain and downtime while aiming to achieve smooth skin and a glowing complexion for our patients." Catering to the increasing popularity of gentle yet effective non-invasive treatments, AuraLux unlocks a significant new revenue stream, driving practice growth, repeat visits and referrals. This makes AuraLux the ideal investment for new and existing aesthetic practices building a thriving laser practice with cost-effective technology that can replace multiple devices with one FDA-cleared system. Its sleek and luxurious 'tabletop' design, featuring an intuitive GUI and built-in safety settings, integrates seamlessly into all practice types. About AuraLux™AuraLux is a breakthrough in cold fiber laser technology, offering a safe, virtually painless and effective solution for total skin health. Its chic design and user-friendly interface make it easy to use on all skin types, providing one of the quickest ROIs ever experienced from a laser purchase. With its minimal downtime, speedy recovery and high accessibility, AuraLux is a game-changer that leaves patients with a radiant glow, timeless youth and boosted confidence. For more information, log on to About Acclaro MedicalFounded in 2018 by world-class industry experts, Acclaro Medical is committed to developing, innovating and bringing to market groundbreaking solutions to address today's unmet medical, aesthetic and surgical practice needs. Acclaro Medical continues to push the boundaries and drive positive change in the aesthetic medical industry. Its flagship UltraClear 2910nm Fiber Laser featuring proprietary 3DIntelliPulse™, 3DMIRACL® and Laser Coring™ skin rejuvenation treatments are valued for delivering unrivaled aesthetic results complemented by high patient comfort, rapid healing and utmost safety across all skin types. For more information, please visit Media Contact:Nadine Tosk,Nadine Tosk Communicationsnadinepr@ 504.453.8344 1 per mechanism of action View original content to download multimedia: SOURCE Acclaro Medical Corporation
